Global Rheumatic Heart Disease Management

Global Rheumatic Heart Disease Management Industry Poised for Steady Growth at 4.5% CAGR, Reaching US$2.04 Billion by 2033 | FMI

The Global Rheumatic Heart Disease Management Industry is on an upward trajectory, with a projected valuation of US$2.04 billion by 2033. According to Future Market Insights (FMI), the market is expected to reach US$1.31 billion by 2023 and soar at a steady Compound Annual Growth Rate (CAGR) of 4.5% over the next decade. This significant …

Continue reading “Global Rheumatic Heart Disease Management Industry Poised for Steady Growth at 4.5% CAGR, Reaching US$2.04 Billion by 2033 | FMI”

Global Rheumatic Heart Disease Management Industry Poised to Exceed US$ 2.04 Billion by 2033, Driven by a Solid 4.5% CAGR | FMI

The Global Rheumatic-Heart Disease Management Industry is poised for a remarkable trajectory, with a projected worth of US$1.31 billion in 2023. According to leading market analysts at Future Market Insights (FMI), the demand for the management of rheumatic heart disease is expected to surge at a Compound Annual Growth Rate (CAGR) of 4.5% between 2023 …

Continue reading “Global Rheumatic Heart Disease Management Industry Poised to Exceed US$ 2.04 Billion by 2033, Driven by a Solid 4.5% CAGR | FMI”